MedPath

DAYBUE

DAYBUE

Approved
DIN Number

02552523

Drug Class

Human

Market Date

Feb 12, 2025

Company
HC

ACADIA Pharmaceuticals, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02552523
AIG Number0166284001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX24 TROFINETIDE
Product Specifications
Dosage FormSolution
Route of AdministrationGastric ,  Oral
AHFS Classification28:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TROFINETIDEActive
Strength: 200 MG / ML
Monograph: TROFINETIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.